10X Genomics Inc
NASDAQ:TXG
10X Genomics Inc
NASDAQ:TXG
Price:
27.48 USD
4.53%
Market Closed
Updated:
May 5, 2024
Section:
Relative Value
The Relative Value of one
TXG
stock under the Base Case scenario is
50.57
USD.
Compared to the current market price of 27.48 USD,
10X Genomics Inc
is
Undervalued by 46%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TXG
Relative Value
Base Case
50.57
USD
Undervaluation 46%
Valuation Multiples
Multiples Across Competitors
TXG Competitors Multiples
10X Genomics Inc Competitors
10X Genomics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
10X Genomics Inc
NASDAQ:TXG
|
3.3B USD | 5.3 | -12.4 | -12.6 | -10.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.3B USD | 5.2 | 36.9 | 22.8 | 33.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
184B USD | 4.2 | 22.8 | 16.6 | 20.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.5B CHF | 5.6 | 57.3 | 19.7 | 28.9 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
40.5B USD | 2.7 | 29.9 | 16.3 | 25.2 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
40.9B USD | 6.1 | 33.1 | 26.4 | 31.8 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
54.9T KRW | 14.9 | 64 | 33.7 | 48.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.2 | 23.9 | 26.5 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.6B USD | 9.1 | 46.9 | 32.5 | 39.5 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.6B USD | 3.1 | 37.4 | 16.9 | 26 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19.2B EUR | 7.1 | 75.4 | 32.4 | 53.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
